Tag: Alnylam Pharmaceuticals

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Alnylam Pharmaceuticals

Gearing Up to Challenge Pfizer in a Rare Disease, BridgeBio Secures Up to $1.25B

Added to Collection on: 2024-01-18 22:54:34

Tags for this article:

Amyloidosis
Neurological disorders
Orphan drugs
Alnylam Pharmaceuticals
Therapeutic gene modulation
RNA
Tafamidis
Familial amyloid polyneuropathy
Acoramidis
Pfizer
RNA interference
BridgeBio Pharma

Click the tags to see associated articles and topics

View Article Details
Alnylam (ALNY) Q4 Loss Narrower Than Expected, Stock Dips 10% - February 16, 2024

Added to Collection on: 2024-02-16 17:03:48

Tags for this article:

Small interfering RNA
Orphan drugs
RNA
Therapeutic gene modulation
Alnylam Pharmaceuticals
Molecular genetics
Patisiran
RNA interference
Familial amyloid polyneuropathy
Amyloidosis
Vutrisiran
Regeneron Pharmaceuticals
Alnylam Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Biotech Boom: Biotechnology Services Market Explores Size, - openPR.com

Added to Collection on: 2024-03-11 16:51:41

Tags for this article:

American brands
Healthcare in India
Pharmaceuticals policy
Science and technology in the People's Republic of China
Pharmaceutical industry in China
Pharmacy in China
Pharmaceutical industry in India
Novartis
Sanofi
IQVIA
Thermo Fisher Scientific
Alnylam Pharmaceuticals
Biotechnology Services MarketThe Business Research Company

Click the tags to see associated articles and topics

View Article Details
Analysts Express Confidence in Alnylam's Hypertension Drug Despite Mixed Trial Data

Added to Collection on: 2024-04-08 19:35:42

Tags for this article:

Chloroarenes
Alnylam Pharmaceuticals
Therapeutic gene modulation
Antihypertensive agents
Cardiovascular physiology
Hypertension
Indapamide
Antihypertensive drug
Olmesartan
Blood pressure
Amlodipine
Essential hypertension
Alnylam Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
RNAi Therapeutics Market Size Expected to Reach USD 4.28 Bn by 2033

Added to Collection on: 2024-05-15 15:08:16

Tags for this article:

RNA
Gene expression
Molecular genetics
Molecular biology
RNA interference
Small interfering RNA
Alnylam Pharmaceuticals
RNA silencing
RNA therapeutics
United States

Click the tags to see associated articles and topics

View Article Details
ALNY: 3 Biotech Stocks With Sky-High Price Targets - StockNews.com

Added to Collection on: 2024-06-21 19:15:20

Tags for this article:

Financial markets
Capital
Private sector
Stock market
Alnylam Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
One firm, two conflicting takes on Alnylam's HELIOS-B - STAT News

Added to Collection on: 2024-06-25 14:23:57

Tags for this article:

Alnylam Pharmaceuticals
Therapeutic gene modulation
Arylcyclohexylamines
Ketones
Nicotinic antagonists
Sedatives
GLP-1 receptor agonist
Sleep apnea
Ketamine
Anti-obesity medication
Continuous positive airway pressure
Pharmaceutical industry

Click the tags to see associated articles and topics

View Article Details
RNA Therapeutics Market Size 2024 High-growth Segments and their Share Forecast till 2028

Added to Collection on: 2024-07-14 22:24:33

Tags for this article:

RNA
Alnylam Pharmaceuticals
RNA interference
Moderna
RNA therapeutics
MRNA vaccine
Small interfering RNA
Novartis
Arbutus Biopharma
Sanofi
BioNTech
Arcturus Therapeutics

Click the tags to see associated articles and topics

View Article Details
3 Biopharma Stocks to Buy for Long-Term Growth - TradingView

Added to Collection on: 2024-07-15 20:12:13

Tags for this article:

Alnylam Pharmaceuticals
Therapeutic gene modulation
Illumina Inc.

Click the tags to see associated articles and topics

View Article Details
VCs investing in cell engineering for drug discovery - Vator News

Added to Collection on: 2024-07-30 21:25:02

Tags for this article:

Biotechnology
Molecular genetics
Molecular biology
Genetic engineering
RNA
RNA interference
Gene therapy
CRISPR gene editing
Alnylam Pharmaceuticals
Editas Medicine
Stem cell
Synthetic biology

Click the tags to see associated articles and topics

View Article Details